Chemoinformaics analysis of 3-PHENYLPROPYL (E)-3-PHENYLPROP-2-ENOATE
| Molecular Weight | 266.34 | nRot | 6 |
| Heavy Atom Molecular Weight | 248.196 | nRig | 3 |
| Exact Molecular Weight | 266.131 | nRing | 2 |
| Solubility: LogS | -6.618 | nHRing | 0 |
| Solubility: LogP | 8.971 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 2 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 12 |
| nHA | 2 | APOL | 43.6663 |
| nHD | 0 | BPOL | 20.6617 |
| QED | 0.199 |
| Synth | 2.509 |
| Natural Product Likeliness | 0.677 |
| NR-PPAR-gamma | 0.979 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.007 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -5.007 |
| MDCK | 0.0000192 |
| BBB | 0.003 |
| PPB | 1.02727 |
| VDSS | 1.228 |
| FU | 0.00198096 |
| CYP1A2-inh | 0.144 |
| CYP1A2-sub | 0.167 |
| CYP2c19-inh | 0.625 |
| CYP2c19-sub | 0.101 |
| CYP2c9-inh | 0.167 |
| CYP2c9-sub | 0.998 |
| CYP2d6-inh | 0.013 |
| CYP2d6-sub | 0.066 |
| CYP3a4-inh | 0.219 |
| CYP3a4-sub | 0.01 |
| CL | 2.845 |
| T12 | 0.21 |
| hERG | 0.031 |
| Ames | 0.068 |
| ROA | 0.012 |
| SkinSen | 0.967 |
| Carcinogencity | 0.092 |
| EI | 0.912 |
| Respiratory | 0.859 |
| NR-Aromatase | 0.636 |
| Antiviral | No |
| Prediction | 0.698138 |